Research

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194May 8, 2012

Penn Vet’s Field Service Tends to the Farms

KENNETT SQUARE — It’s a quaint image: a rural vet in a pick-up truck driving down a country lane to treat a sick cow or horse.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659May 8, 2012

Penn Receives $25 Million Gift to Create Basser Research Center for Inherited Cancers

PHILADELPHIA — A $25 million gift to the University of Pennsylvania from alumni Mindy and Jon Gray will establish a center focused on the treatment and prevention of cancers associated with hereditary BRCA mutations.

The Basser Research Center — BRC for BRCA — will support research on the BRCA1 and BRCA2 genes, harmful forms of which are linked to greatly increased risks of developing breast and ovarian cancer.  The Center is named in honor of Mindy Gray’s sister, Faith Basser, who died of ovarian cancer at age 44.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604May 7, 2012

Penn’s Steve Fluharty Has a Hand in the “Golden Goose” Awards Highlighting Basic Research

PHILADELPHIA -- Steve Fluharty, the University of Pennsylvania’s senior vice provost for research, is participating in a new congressional program that will highlight federally funded science projects. Called the “Golden Goose Awards,” not just any projects will do; the program exists to draw attention to the sometimes-serendipitous nature of scientific progress.

Gene Therapy Safe in Decade-Long HIV Study That May Widen Use

May 2, 2012

Bruce Levine and Carl June of the Perelman School of Medicine are highlighted for their gene therapy research.

Article Source: Business Week

Disabled Americans Shrink Size of U.S. Labor Force

May 3, 2012

Mark Duggan of the Wharton School is cited for a research paper about unemployment.

Article Source: Business Week
facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658May 3, 2012

NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine

After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659May 2, 2012

Genetically Modified T Cell Therapy Shown to Be Safe, Lasting in Penn Medicine Study of HIV Patients

HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.

facebook twitter google print email
Media Contact:Jill DiSanto | jdisanto@upenn.edu | 215-898-4820May 3, 2012

Penn’s Center for High Impact Philanthropy Launches Development of Child-Survival Tool Kit for Donors

Each year, before reaching age age 5, almost 8 million children die from preventable causes. The University of Pennsylvania’s Center for High Impact Philanthropy at the School of Social Policy & Practice is doing something about it.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194May 1, 2012

Three Penn Faculty Elected to the National Academy of Sciences

PHILADELPHIA — Nancy Bonini, Gideon Dreyfuss and Beatrice H. Hahn of the University of Pennsylvania have been elected members of the National Academy of Sciences, considered one of the highest honors that can be accorded a U.S. scientist or engineer.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604April 30, 2012

Penn Scientists Develop Large-scale Simulation of Human Blood

PHILADELPHIA — Having a virtual copy of a patient’s blood in a computer would be a boon to researchers and doctors. They could examine a simulated heart attack caused by blood clotting in a diseased coronary artery and see if a drug like aspirin would be effective in reducing the size of such a clot.